GB Patent

GB864100A — Therapeutic pencillin compositions and the preparation thereof

Assigned to Pfizer Inc · Expires 1961-03-29 · 65y expired

What this patent protects

Injectable suspensions comprise an aqueous suspension of a water-insoluble salt of penicillin and 0.5 to 10% of choline or a water-soluble derivative thereof. About 3 to 10% of urea or a derivative, 1 to 5% of a parenterally acceptable suspending agent and about 0.25 to 5% (base…

USPTO Abstract

Injectable suspensions comprise an aqueous suspension of a water-insoluble salt of penicillin and 0.5 to 10% of choline or a water-soluble derivative thereof. About 3 to 10% of urea or a derivative, 1 to 5% of a parenterally acceptable suspending agent and about 0.25 to 5% (based on the weight of the penicillin salt) of a parenterally acceptable buffer. Preservatives may also be added. The penicillin salt may be that with procaine, dibenzylethylenediamine, N - benzyl - N1 - (3 - ethoxy - 4 - hydroxy)-benzyl ethylenediamine, 2-chloroprocaine and N,N1 - di - (4 - methoxybenzyl) ethylene diamine. The choline derivative may be the chloride, dihydrogen tartrate, dihydrogen citrate or chloride carbamate. Examples of urea derivatives are thiocarbamide, carbamyl chloride, urea nitrate, thiomethane, lower (up to four carbon atoms) alkyl carbamates.

Drugs covered by this patent

Patent Metadata

Patent number
GB864100A
Jurisdiction
GB
Classification
Expires
1961-03-29
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.